Literature DB >> 11156098

Operation for adult patent ductus arteriosus using cardiopulmonary bypass.

R Toda1, Y Moriyama, M Yamashita, Y Iguro, H Matsumoto, G Yotsumoto.   

Abstract

BACKGROUND: Surgical repair of adult patent ductus arteriosus is more hazardous than when performed on young patients.
METHODS: Nine adult patent ductus arteriosus patients underwent surgical repair between January 1986 and December 1998. There were 3 male and 6 female patients (mean age 55.0 years). The ratio of pulmonary blood flow to systemic flow was 2.40 +/- 0.95, and pulmonary arterial pressure was 56.0 +/- 26.4 mm Hg. The operation was performed using transpulmonary approach under total cardiopulmonary bypass. Balloon occlusion method was also utilized.
RESULTS: Direct closure was made in 5 and patch closure in 4 patients. Cardiopulmonary bypass and balloon occlusion were safely established. Cardioplegic arrest was not required in the 2 most recent patients. No operative death has occurred. Pulmonary arterial systolic pressure decreased to 35.3 +/- 6.6 mm Hg at 6 months after operation. The mean follow-up period for all patients is 55 months. To date, neither recannalization of the ductus nor pseudoaneurysm has been recognized.
CONCLUSIONS: Cardiopulmonary bypass with balloon occlusion provides a safe operation for adult patients with complicated patent ductus arteriosus.

Entities:  

Mesh:

Year:  2000        PMID: 11156098     DOI: 10.1016/s0003-4975(00)01702-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Percutaneous closure of patent ductus arteriosus in an asymptomatic adult.

Authors:  Margaret M Sullivan; Kevin P Theleman; James W Choi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

2.  Young Adult Patent Ductus Arteriosus Treated with Endovascular Stent Grafting.

Authors:  Pin-Hung Liu; Pei-Leun Kang; Yu-Hsin Lin
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

Review 3.  Transpulmonary surgical closure of patent ductus arteriosus with hypothermic circulatory arrest in an adult patient.

Authors:  Ugur Gurcun; Mehmet Boga; M Ismail Badak; Erdem Ali Ozkisacik; Berent Discigil
Journal:  Tex Heart Inst J       Date:  2005

4.  Endovascular aortic repair of patent ductus arteriosus in an adult patient.

Authors:  Kentaro Yamabe; Hideyuki Shimizu; Atsushi Nemoto; Ryohei Yozu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-28

5.  A case of pulmonary infective endarteritis associated with patent ductus arteriosus: surgical closure under circulatory arrest.

Authors:  Seiji Matsukuma; Kiyoyuki Eishi; Kouji Hashizume; Takashi Oshitomi; Tsuneo Ariyoshi; Shinichiro Taniguchi; Kazuki Hisatomi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-08-18

6.  Thoracic endovascular aortic repair for patent ductus arteriosus in an elderly patient with congestive heart failure.

Authors:  Gentaro Kato; Mikizo Nakai; Noriyuki Tokunaga; Shuji Shimizu; Masahiro Okada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-24

7.  Use of a Stent Graft for Patent Ductus Arteriosus in an Octogenarian Eliminates Ductus Flow.

Authors:  Wataru Tatsuishi; Go Kataoka; Ryota Asano; Atsuhiko Sato; Kiyoharu Nakano
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-09-04       Impact factor: 1.520

8.  Large patent ductus arteriosus in an adult complicated by pulmonary endarteritis and embolic lung abscess.

Authors:  Manoraj Navaratnarajah; Kwabena Mensah; Mahesh Balakrishnan; Shahzad G Raja; Toufan Bahrami
Journal:  Heart Int       Date:  2011-10-21

9.  Thoracic endovascular repair technique for the treatment of patent ductus arteriosus in an elderly patient: A case report.

Authors:  Jung Hee Kim; Jong Hyun Baek
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

10.  Transcatheter Closure of Patent Ductus Arteriosus in Elderly Patients: Initial and One-Year Follow-Up Results-Do We Have the Proper Device?

Authors:  Michal Galeczka; Malgorzata Szkutnik; Jacek Bialkowski; Sebastian Smerdzinski; Mateusz Knop; Adam Sukiennik; Roland Fiszer
Journal:  J Interv Cardiol       Date:  2020-04-29       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.